Synthesis, characterization and antimicrobial activity evaluation of new imidazo [2,1-b][1,3,4]thiadiazole derivatives

Shankar Gaddeppa Alegaon, Kallanagouda Ramappa Alagawadi


Imidazo[2,1-b][1,3,4]thiadiazoles (4a-g) were synthesized from 3,4,5-trimethoxy benzoic acid and thiosemicarbazide. Reaction of 4 with Vilsmeier-Haack reagent yielded imidazo [2,1-b][1,3,4] thiadiazole–5-carbaldehyde derivatives (5a-g). Obtained imidazo[2,1-b][1,3,4] thiadia zoles-5-carbaldehydes were subjected to Knoevenagel condensation with 2-(2,4-dioxothia zolidin-3-yl)acetic acid (1) and 2-(4-oxo-2-thioxothiazolidin-3-yl)acetic (2) in the presence of catalytic amount of piperidine and acetic acid to afford imidazo[2,1-b][1,3,4]thiadiazoles (6a-g) and (7a-g), respectively. The structures of the newly synthesized compounds were confirmed by IR, NMR and elemental analyses. All compounds were screened for their antibacterial and antifungal activities. Some of the compounds displayed good antibacterial and antifungal activity.



Thiazolidinedione; Thiadiazole; Imidazo[2,1-b][1,3,4]thiadiazoles; Antibacterial activity; Antifungal activity; Rhodanine

European Journal of Chemistry, 2 (1), (2011), 94-99

Full Text:

PDF    /    /




[1]. Azodicarboxylates: valuable reagents for the multicomponent synthesis of novel 1,3,4-thiadiazoles and imidazo[2,1-b][1,3,4]thiadiazoles
Tryfon Zarganes-Tzitzikas, Constantinos G. Neochoritis, Julia Stephanidou-Stephanatou, Constantinos A. Tsoleridis, Gernot Buth, George E. Kostakis
Tetrahedron  Volume: 69  Issue: 24  First page: 5008  Year: 2013  

[2]. Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of fused [1,3,4]thiadiazoles
Nadia S. El-Gohary, Mona I. Shaaban
European Journal of Medicinal Chemistry  Volume: 63  First page: 185  Year: 2013  

[3]. Relevance of weak intermolecular forces on the supramolecular structure of free or DMSO solvated 5-(4-X-benzylidene)rhodanines (X = F, Cl, Br, I)
José S. Casas, M. Victoria Castaño, María D. Couce, Agustín Sánchez, José Sordo, M. Dolores Torres, Saulo A. Vázquez, Ezequiel M. Vázquez-López
Journal of Molecular Structure  Volume: 1120  First page: 100  Year: 2016  

[4]. Microwave promoted one-pot synthesis of 2-aryl substituted 1,3,4-oxadiazoles and 1,2,4-oxadiazole derivatives using Al3+-K10 clay as a heterogeneous catalyst
Dhanusu Suresh, Kuppusamy Kanagaraj, Kasi Pitchumani
Tetrahedron Letters  Volume: 55  Issue: 27  First page: 3678  Year: 2014  

[5]. New thiazolidine-2,4-diones as antimicrobial and cytotoxic agent
Shankar G. Alegaon, Kallanagouda R. Alagawadi
Medicinal Chemistry Research  Volume: 21  Issue: 10  First page: 3214  Year: 2012  

[6]. Reinvestigation of 1,3,4-Thiadiazol-2(3H)-iminium Bromide in the Two-Step Synthesis of Imidazo[2,1-b][1,3,4]thiadiazoles
Shigeki Sano, Keisuke Matsuura, Hayato Sumiyoshi, Akira Miki, Syuji Kitaike, Michiyasu Nakao
HETEROCYCLES  Volume: 89  Issue: 4  First page: 1041  Year: 2014  

[7]. Biological activities of imidazo[2,1-b][1,3,4]thiadiazole derivatives: A review
Bhoomendra A. Bhongade, Sirajunisa Talath, Ravikiran A. Gadad, Andanappa K. Gadad
Journal of Saudi Chemical Society  Year: 2013  

[8]. Antimicrobial and Antiquorum-Sensing Studies. Part 3: Synthesis and Biological Evaluation of New Series of [1,3,4]Thiadiazoles and Fused [1,3,4]Thiadiazoles
Nadia S. El-Gohary, Mona I. Shaaban
Archiv der Pharmazie  Volume: 348  Issue: 4  First page: 283  Year: 2015  



[1]. Tenover, F. C.; McDonald, L. C. Curr. Opin. Infect. Dis. 2005, 18, 300-305.

[2]. Pfeltz, R. F.; Wilkinson, B. J. Curr. Drug. Targets Infect. Disord. 2004, 4, 273-294.

[3]. Roberts, M. C. Curr. Drug. Targets Infect. Disord. 2004, 4, 207-215.

[4]. Dessen, A.; Di Guilmi, A. M.; Vernet, T.; Dideberg, O. Curr. Drug. Targets Infect. Disord. 2001, 1, 63-77.

[5]. Muroi, H.; Nihei, K.; Tsujimoto, K, and Kubo, I. Bioorg. Med. Chem. 2004, 12, 583-587.

[6]. Chopra, I.; Schofield, C.; Everett, M.; O’Neill, K.; Miller, K.; Wilcox, M. Lancet Infect, Dis. 2008, 8, 133-139.

[7]. Terzioglu, N.; Gursoy, A. Eur. J. Med. Chem. 2003, 38, 781-786.

[8]. Kolavi, G.; Hegde, V.; Khazi, I M.; Gadad, P. Bioorg. Med. Chem. 2006, 14, 3069-3080.

[9]. Gadad, A. K.; Mahajanshetti, C. S.; Nimbalkar, S.; Raichurkar, A. Eur. J. Med. Chem. 2000, 35, 853-857.

[10]. Andotra, C. S.; Langer, T. C.; Kotha, A. J. Indian Chem Soc. 1997, 72, 125-127.

[11]. Kumar, P. Chinese J. Chem. 2010, 28, 250-254.

[12]. Andreani, A.; Bonazzi, D.; Rambaldi, M.; Fabbri, G.; Rainsford, K. D. Eur. J. Med. Chem. 1982, 17, 271-274.

[13]. Bhovi, V. K.; Bodke, Y. D. Current Chem. Biol. 2010, 4, 145-150.

[14]. Khazi, I. A. M.; Mahajanshetti, C. S.; Gadad, A. K.; Tarnalli, A. D.; Sultanpur, C. M. Arzneimittelforschung. 1996, 46, 949-952.

[15]. Andreani, A.; Leonia, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Simon, W. A.; Senn-Bilfinger, J. Arzneimittelforschung. 2000, 50, 550-553.

[16]. Andreani, A.; Rambaldi, M.; Mascellani, G.; Bossa, R.; Galatulas, I. Eur. J. Med. Chem. 1986, 21, 451-453.

[17]. Andreani, A.; Rambaldi, M.; Mascellani, G.; Rugarli, P. Eur. J. Med. Chem. 1987, 22, 19-22.

[18]. Andreani, A.; Rambaldi, M.; Locatelli, A.; Andreani, F. Collect. Czech. Chem. Commun. 1991, 56, 2436-2447.

[19]. Terashima, H.; Hama, K.; Yamamoto, R.; Tsuboshima, M.; Kikkawa, I. and Shigata, Y. J. Pharmacol. Exp. Ther. 1984, 229, 226-230.

[20]. Yoshioka, T.; Fujita, T.; Kanai, T.; Aizawa,Y.; Kurumada, T.; Hasegawa, K.; Horikoshi, H. J. Med. Chem. 1989, 32, 421-428.

[21]. Ayhan-Kilcigil, G.; Altanlar, N. Arzneimittelforschung. 2000, 50, 154-157.

[22]. Heerding, D. A.; Christmann, L. T.; Clark, T. J.; Holmes, D. J.; Rittenhouse, S. F.; Takata, D. T.; Venslavsky, J. W. Med. Chem. Lett. 2003, 13, 3771-3773.

[23]. Tuncbilek, M.; Altanlar N. Arch. Pharm. Chem. Life Sci. 2006, 339, 213-216.

[24]. Bozdag-Dundar, O.; Ozgen, O.; Mentese, A.; Altanlar, N.; Atli, O.; Kendi, E.; Ertan, R. Bioorg. Med. Chem. 2007, 15, 6012- 6017.

[25]. Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. L. J. Med. Chem. 1994, 37, 3977-3985.

[26]. Andreani, A.; Rambaldi, M.; Locatelli, A.; Leoin, A.; Bossa, R.; Chiericozzi, M.; Galatulas, I.; Salvatore, G. Eur. J. Med. Chem. 1993, 28, 825-829.

[27]. De Lima, J. G.; Perrissin, M.; Chantegrel, J. Arzneimittelforschung. 1994, 44, 831-834.

[28]. Boschelli, D. H.; Connor, D. T.; Kuipers, P. J.; Wright, C. D. Bioorg. Med. Chem. Lett. 1992, 2, 705-708.

[29]. Al-Omar, M.; Al-Deeb, A.; Al-Khamees.; El-Emam, A. A. Phosphorus, Sulfur, and Silicon. 2004, 179, 2509-2517.

[30]. Mazzone, G.; Bonina, F.; Puglisi, G.; Arrigo, R. R.; Cosentino, C.; Blandino, G. Farmaco Sci. 1982, 37, 685-700.

[31]. Maccari, R.; Ottana, R.; Curinga, C.; Vigorita, M. G.; Rakowitz, D.; Steindl, T.; Langer, T. Bioorg. Med. Chem. 2005, 13, 2809-2823.

[32]. CLSI/NCCLS Guidelines: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; 7th Ed. Approved Standard document M-7:A5, Villanova, PA, NCCLS, 2006.


  • There are currently no refbacks.